Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 1
2011 2
2012 1
2013 2
2015 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Innate and adaptive immune cells in the tumor microenvironment.
Gajewski TF, Schreiber H, Fu YX. Gajewski TF, et al. Nat Immunol. 2013 Oct;14(10):1014-22. doi: 10.1038/ni.2703. Nat Immunol. 2013. PMID: 24048123 Free PMC article. Review.
Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Spranger S, Spaapen RM, Zha Y, Williams J, Meng Y, Ha TT, Gajewski TF. Spranger S, et al. Sci Transl Med. 2013 Aug 28;5(200):200ra116. doi: 10.1126/scitranslmed.3006504. Sci Transl Med. 2013. PMID: 23986400 Free PMC article.
Cancer immunotherapy.
Gajewski TF. Gajewski TF. Mol Oncol. 2012 Apr;6(2):242-50. doi: 10.1016/j.molonc.2012.01.002. Epub 2012 Jan 8. Mol Oncol. 2012. PMID: 22248437 Free PMC article. Review.
Molecular profiling of melanoma and the evolution of patient-specific therapy.
Gajewski TF. Gajewski TF. Semin Oncol. 2011 Apr;38(2):236-42. doi: 10.1053/j.seminoncol.2011.01.004. Semin Oncol. 2011. PMID: 21421113 Free PMC article. Review.
Costimulatory and coinhibitory receptors in anti-tumor immunity.
Driessens G, Kline J, Gajewski TF. Driessens G, et al. Immunol Rev. 2009 May;229(1):126-44. doi: 10.1111/j.1600-065X.2009.00771.x. Immunol Rev. 2009. PMID: 19426219 Free PMC article. Review.
Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment.
Gajewski TF, Fuertes M, Spaapen R, Zheng Y, Kline J. Gajewski TF, et al. Curr Opin Immunol. 2011 Apr;23(2):286-92. doi: 10.1016/j.coi.2010.11.013. Epub 2010 Dec 23. Curr Opin Immunol. 2011. PMID: 21185705 Free PMC article. Review.
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.
Mikucki ME, Fisher DT, Matsuzaki J, Skitzki JJ, Gaulin NB, Muhitch JB, Ku AW, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS. Mikucki ME, et al. Nat Commun. 2015 Jun 25;6:7458. doi: 10.1038/ncomms8458. Nat Commun. 2015. PMID: 26109379 Free PMC article.
T cell-NF-κB activation is required for tumor control in vivo.
Barnes SE, Wang Y, Chen L, Molinero LL, Gajewski TF, Evaristo C, Alegre ML. Barnes SE, et al. J Immunother Cancer. 2015 Jan 20;3(1):1. doi: 10.1186/s40425-014-0045-x. eCollection 2015. J Immunother Cancer. 2015. PMID: 25648675 Free PMC article.
11 results
Jump to page